| Date Filed | Type | Description |
| 06/28/2023 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 37,500 options to buy
@ $1.85, valued at
$69.4k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/25/2020 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 80,000 options to buy
@ $1.28, valued at
$102.4k
|
|
| 12/13/2019 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 534 options to buy
@ $56.25, valued at
$30k
Disposed/sold 1,600 options to buy
@ $82.35, valued at
$131.8k
Disposed/sold 1,200 options to buy
@ $62.1, valued at
$74.5k
Disposed/sold 2,400 options to buy
@ $81.6, valued at
$195.8k
Disposed/sold 2,400 options to buy
@ $14.25, valued at
$34.2k
Disposed/sold 6,000 options to buy
@ $16.55, valued at
$99.3k
Disposed/sold 6,000 options to buy
@ $2.36, valued at
$14.2k
Disposed/sold 12,000 options to buy
@ $1.94, valued at
$23.3k
|
|
| 06/14/2019 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Cellectar Biosciences, Inc.|
Txns:
| Granted 9,750 options to buy
@ $2.15, valued at
$21k
|
|
| 06/14/2019 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Granted 12,000 options to buy
@ $1.94, valued at
$23.3k
|
|
| 01/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2018 |
4
| Swirsky Douglas J (President and CEO) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.|
Txns:
| Granted 500,000 options to buy
@ $1.09, valued at
$545k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2018 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Granted 6,000 options to buy
@ $2.36, valued at
$14.2k
|
|
| 05/23/2018 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 25,000 options to buy
@ $2.63, valued at
$65.8k
|
|
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/17/2017 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on PERNIX THERAPEUTICS HOLDINGS, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.97, valued at
$148.5k
|
|
| 11/17/2017 |
3
| Swirsky Douglas J (Director) has filed a Form 3 on PERNIX THERAPEUTICS HOLDINGS, INC. |
| 06/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/18/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 09/16/2016 |
4
| Swirsky Douglas J (President & CEO) has filed a Form 4 on GENVEC INC|
Txns:
| Bought 10,000 shares
@ $0.5, valued at
$5k
|
|
| 06/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/01/2016 |
4
| Swirsky Douglas J (President & CEO) has filed a Form 4 on GENVEC INC|
Txns:
| Granted 250,000 options to buy
@ $0.56, valued at
$140k
|
|
| 12/15/2015 |
4
| Swirsky Douglas J (President & CEO) has filed a Form 4 on GENVEC INC|
Txns:
| Bought 5,000 shares
@ $2, valued at
$10k
|
|
| 08/07/2015 |
4/A
| Swirsky Douglas J (President & CEO) has filed a Form 4 on GENVEC INC|
Txns:
| Bought 5,500 shares
@ $1.9, valued at
$10.5k
|
|
| 06/25/2015 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Granted 36,000 options to buy
@ $5.44, valued at
$195.8k
|
|
| 01/16/2015 |
4
| Swirsky Douglas J (President & CEO) has filed a Form 4 on GENVEC INC|
Txns:
| Granted 200,000 options to buy
@ $2.97, valued at
$594k
|
|
| 12/15/2014 |
4
| Swirsky Douglas J (President & CEO) has filed a Form 4 on GENVEC INC|
Txns:
| Granted 5,500 shares
@ $1.9, valued at
$10.5k
|
|
| 06/24/2014 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Granted 18,000 options to buy
@ $4.14, valued at
$74.5k
|
|
|